Effetto | Estimate | S.E. | Pr > |t| |
---|---|---|---|
Intercept | 6.10 | 1.12 | < 0.001 |
Treatment E + Hy | −0.32 | 0.38 | 0.41 |
Treatment ESWT-al (reference group) | |||
Time Follow-up 2 | −1.87 | 0.34 | < 0.001 |
Time Follow-up 1 | −1.98 | 0.34 | < 0.001 |
Baseline (reference group) | |||
Time Follow-up 2 Treatment E + Hy | −1.85 | 0.39 | < 0.001 |
Time Follow-up 2 Treatment ESWT-al (reference group) | |||
Time Follow-up 1 Treatment E + Hy | −0.67 | 0.34 | 0.05 |
Time Follow-up 1 Treatment ESWT-al (reference group) | |||
Baseline (reference group) | |||
Sex Male | 0.65 | 0.37 | 0.10 |
Sex Female (reference group) | |||
Time Follow-up 2 Sex Male | −1.45 | 0.38 | < 0.001 |
Time Follow-up 2 Sex Female (reference group) | |||
Time Follow-up 1 Sex Male | 0.08 | 0.38 | 0.85 |
Time Follow-up 1 Sex Female (reference group) | |||
Shoulder pain side right | −0.70 | 0.32 | 0.03 |
Shoulder pain side left (reference group) | |||
Age (yy) | 0.01 | 0.02 | 0.44 |